Physician profile
Roy J Guse
NPI 1215984356
$2,279.73
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $1,181 · 2021: $391 · 2022: $275.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,056.64 | 2020 | |
| Stryker Corporation | $358.28 | 2019-2022 | |
| Pacira Therapeutics, INC. | $269.51 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $140.94 | 2019-2021 | |
| Depuy Synthes Sales INC. | $120.90 | 2019-2022 | |
| Davol INC. | $65.26 | 2022 | |
| Next Science LLC | $51.39 | 2021 | |
| Bioventus LLC | $48.74 | 2019-2021 | |
| Avanos Medical | $32.78 | 2019 | |
| Medtronic USA, INC. | $30.09 | 2019 | |
| Ferring Pharmaceuticals INC. | $27.19 | 2019 | |
| Baxter Healthcare | $22.13 | 2022 | |
| Smith+Nephew, INC. | $16.22 | 2019 | |
| Siemens Medical Solutions USA, INC. | $14.98 | 2019 | |
| Fidia Pharma USA INC. | $13.37 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $11.31 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Guse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.